(Q50916955)

English

Activation of the PI3K/Akt pathway by oxidative stress mediates high glucose-induced increase of adipogenic differentiation in primary rat osteoblasts.

scientific article published in November 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/23757055

Activation of the PI3K/Akt pathway by oxidative stress mediates high glucose-induced increase of adipogenic differentiation in primary rat osteoblasts. (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/23757055

0 references

author name string

Yu Zhang

1

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/23757055

Jian-Hong Yang

2

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/23757055

publication date

1 November 2013

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/23757055

Journal of Cellular Biochemistry

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/23757055

114

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/23757055

11

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/23757055

2595-2602

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/23757055

PPARgamma insufficiency enhances osteogenesis through osteoblast formation from bone marrow progenitors

1 reference

https://api.crossref.org/works/10.1002%2FJCB.24607

21 January 2018

Phosphoinositide 3-kinase is required for human adipocyte differentiation in culture.

1 reference

https://api.crossref.org/works/10.1002%2FJCB.24607

21 January 2018

Glucose-induced inhibition of in vitro bone mineralization

1 reference

https://api.crossref.org/works/10.1002%2FJCB.24607

21 January 2018

Increased bone adiposity and peroxisomal proliferator-activated receptor-gamma2 expression in type I diabetic mice

1 reference

https://api.crossref.org/works/10.1002%2FJCB.24607

21 January 2018

Osteoblast-targeted overexpression of PPARγ inhibited bone mass gain in male mice and accelerated ovariectomy-induced bone loss in female mice.

1 reference

https://api.crossref.org/works/10.1002%2FJCB.24607

21 January 2018

Hesperetin attenuates the highly reducing sugar-triggered inhibition of osteoblast differentiation

1 reference

https://api.crossref.org/works/10.1002%2FJCB.24607

21 January 2018

High glucose concentrations alter the biomineralization process in human osteoblastic cells

1 reference

https://api.crossref.org/works/10.1002%2FJCB.24607

21 January 2018

Effects of glucose and its modulation by insulin and estradiol on BMSC differentiation into osteoblastic lineages

1 reference

https://api.crossref.org/works/10.1002%2FJCB.24607

21 January 2018

Role of oxidative stress in diabetic bone disorder

1 reference

https://api.crossref.org/works/10.1002%2FJCB.24607

21 January 2018

Thioredoxin-1 overexpression in transgenic mice attenuates streptozotocin-induced diabetic osteopenia: a novel role of oxidative stress and therapeutic implications.

1 reference

https://api.crossref.org/works/10.1002%2FJCB.24607

21 January 2018

Delayed bone regeneration and low bone mass in a rat model of insulin-resistant type 2 diabetes mellitus is due to impaired osteoblast function

1 reference

https://api.crossref.org/works/10.1002%2FJCB.24607

21 January 2018

Sclerostin antibody treatment improves bone mass, bone strength, and bone defect regeneration in rats with type 2 diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1002%2FJCB.24607

21 January 2018

Expression of a constitutively activated form of protein kinase B (c-Akt) in 3T3-L1 preadipose cells causes spontaneous differentiation

1 reference

https://api.crossref.org/works/10.1002%2FJCB.24607

21 January 2018

Understanding the pathology and mechanisms of type I diabetic bone loss.

1 reference

https://api.crossref.org/works/10.1002%2FJCB.24607

21 January 2018

Diabetes Mellitus: Does it Affect Bone?

1 reference

https://api.crossref.org/works/10.1002%2FJCB.24607

21 January 2018

Diabetes mellitus, bone mineral density, and fracture risk

1 reference

https://api.crossref.org/works/10.1002%2FJCB.24607

21 January 2018

Wortmannin, a specific phosphatidylinositol 3-kinase inhibitor, inhibits adipocytic differentiation of 3T3-L1 cells

1 reference

https://api.crossref.org/works/10.1002%2FJCB.24607

21 January 2018

High glucose stimulates adipogenic and inhibits osteogenic differentiation in MG-63 cells through cAMP/protein kinase A/extracellular signal-regulated kinase pathway

1 reference

https://api.crossref.org/works/10.1002%2FJCB.24607

21 January 2018

Inhibition of adipose differentiation by phosphatidylinositol 3-kinase inhibitors

1 reference

https://api.crossref.org/works/10.1002%2FJCB.24607

21 January 2018

Metformin reverses the deleterious effects of high glucose on osteoblast function.

1 reference

https://api.crossref.org/works/10.1002%2FJCB.24607

21 January 2018

Identifiers

10.1002/JCB.24607

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/23757055

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/23757055

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50916955&oldid=956494809"